Annual EBITDA
-$7.60 M
-$19.46 M-164.07%
31 December 2023
Summary:
TherapeuticsMD annual earnings before interest, taxes, depreciation & amortization is currently -$7.60 million, with the most recent change of -$19.46 million (-164.07%) on 31 December 2023. During the last 3 years, it has risen by +$145.81 million (+95.05%). TXMD annual EBITDA is now -164.07% below its all-time high of $11.86 million, reached on 31 December 2022.TXMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$468.00 K
+$397.00 K+45.90%
30 September 2024
Summary:
TherapeuticsMD quarterly earnings before interest, taxes, depreciation & amortization is currently -$468.00 thousand, with the most recent change of +$397.00 thousand (+45.90%) on 30 September 2024. Over the past year, it has increased by +$816.00 thousand (+63.55%). TXMD quarterly EBITDA is now -100.80% below its all-time high of $58.36 million, reached on 31 December 2022.TXMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$3.85 M
+$816.00 K+17.48%
30 September 2024
Summary:
TherapeuticsMD TTM earnings before interest, taxes, depreciation & amortization is currently -$3.85 million, with the most recent change of +$816.00 thousand (+17.48%) on 30 September 2024. Over the past year, it has dropped by -$56.45 million (-107.32%). TXMD TTM EBITDA is now -107.32% below its all-time high of $52.60 million, reached on 30 September 2023.TXMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -164.1% | +63.5% | -107.3% |
| 3 y3 years | +95.0% | +98.8% | +97.2% |
| 5 y5 years | +94.0% | +98.2% | +97.5% |
TXMD EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -164.1% | +95.0% | -100.8% | +98.8% | -107.3% | +97.2% |
| 5 y | 5 years | -164.1% | +95.2% | -100.8% | +99.1% | -107.3% | +97.7% |
| alltime | all time | -164.1% | +95.2% | -100.8% | +99.1% | -107.3% | +97.7% |
TherapeuticsMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$468.00 K(-45.9%) | -$3.85 M(-17.5%) |
| June 2024 | - | -$865.00 K(+28.0%) | -$4.67 M(-22.8%) |
| Mar 2024 | - | -$676.00 K(-63.3%) | -$6.04 M(-20.5%) |
| Dec 2023 | -$7.60 M(-164.1%) | -$1.84 M(+43.5%) | -$7.60 M(-114.4%) |
| Sept 2023 | - | -$1.28 M(-42.7%) | $52.60 M(+33.1%) |
| June 2023 | - | -$2.24 M(+0.3%) | $39.53 M(+45.4%) |
| Mar 2023 | - | -$2.23 M(-103.8%) | $27.18 M(+129.1%) |
| Dec 2022 | $11.86 M(-115.0%) | $58.36 M(-506.4%) | $11.86 M(-166.6%) |
| Sept 2022 | - | -$14.36 M(-1.6%) | -$17.80 M(-59.4%) |
| June 2022 | - | -$14.59 M(-16.8%) | -$43.79 M(-32.2%) |
| Mar 2022 | - | -$17.55 M(-161.1%) | -$64.62 M(-15.5%) |
| Dec 2021 | -$78.84 M(-48.6%) | $28.70 M(-171.1%) | -$76.49 M(-45.2%) |
| Sept 2021 | - | -$40.35 M(+13.9%) | -$139.51 M(+12.5%) |
| June 2021 | - | -$35.42 M(+20.4%) | -$124.03 M(-6.4%) |
| Mar 2021 | - | -$29.41 M(-14.3%) | -$132.55 M(-13.2%) |
| Dec 2020 | -$153.41 M(-3.0%) | -$34.33 M(+38.1%) | -$152.72 M(-5.7%) |
| Sept 2020 | - | -$24.86 M(-43.4%) | -$162.00 M(-0.8%) |
| June 2020 | - | -$43.94 M(-11.4%) | -$163.34 M(-4.2%) |
| Mar 2020 | - | -$49.58 M(+13.7%) | -$170.50 M(+7.8%) |
| Dec 2019 | -$158.23 M(+24.0%) | -$43.62 M(+66.4%) | -$158.23 M(+4.2%) |
| Sept 2019 | - | -$26.21 M(-48.7%) | -$151.81 M(-4.6%) |
| June 2019 | - | -$51.09 M(+36.9%) | -$159.08 M(+13.1%) |
| Mar 2019 | - | -$37.31 M(+0.3%) | -$140.61 M(+10.2%) |
| Dec 2018 | -$127.65 M(+66.4%) | -$37.20 M(+11.1%) | -$127.65 M(+14.2%) |
| Sept 2018 | - | -$33.48 M(+2.6%) | -$111.81 M(+20.3%) |
| June 2018 | - | -$32.62 M(+34.0%) | -$92.95 M(+16.3%) |
| Mar 2018 | - | -$24.34 M(+13.9%) | -$79.95 M(+4.0%) |
| Dec 2017 | -$76.71 M(-14.5%) | -$21.37 M(+46.3%) | -$76.84 M(-1.5%) |
| Sept 2017 | - | -$14.61 M(-25.5%) | -$77.99 M(-11.8%) |
| June 2017 | - | -$19.62 M(-7.6%) | -$88.46 M(-1.7%) |
| Mar 2017 | - | -$21.24 M(-5.7%) | -$90.03 M(+0.3%) |
| Dec 2016 | -$89.74 M(+5.4%) | -$22.51 M(-10.3%) | -$89.74 M(+5.9%) |
| Sept 2016 | - | -$25.09 M(+18.4%) | -$84.72 M(+7.1%) |
| June 2016 | - | -$21.19 M(+1.1%) | -$79.12 M(-7.1%) |
| Mar 2016 | - | -$20.95 M(+19.8%) | -$85.17 M(+0.1%) |
| Dec 2015 | -$85.13 M(+57.9%) | -$17.49 M(-10.2%) | -$85.13 M(+1.4%) |
| Sept 2015 | - | -$19.49 M(-28.5%) | -$83.93 M(+2.0%) |
| June 2015 | - | -$27.24 M(+30.3%) | -$82.26 M(+24.8%) |
| Mar 2015 | - | -$20.91 M(+28.4%) | -$65.90 M(+22.3%) |
| Dec 2014 | -$53.90 M(+109.8%) | -$16.29 M(-8.6%) | -$53.90 M(+18.2%) |
| Sept 2014 | - | -$17.82 M(+63.7%) | -$45.59 M(+30.4%) |
| June 2014 | - | -$10.89 M(+22.2%) | -$34.96 M(+17.8%) |
| Mar 2014 | - | -$8.91 M(+11.7%) | -$29.68 M(+15.4%) |
| Dec 2013 | -$25.69 M(-22.5%) | -$7.98 M(+10.9%) | -$25.71 M(+12.1%) |
| Sept 2013 | - | -$7.19 M(+28.4%) | -$22.93 M(+15.6%) |
| June 2013 | - | -$5.60 M(+13.5%) | -$19.84 M(-20.4%) |
| Mar 2013 | - | -$4.94 M(-4.9%) | -$24.92 M(-24.8%) |
| Dec 2012 | -$33.16 M(+159.2%) | -$5.19 M(+26.6%) | -$33.16 M(-11.5%) |
| Sept 2012 | - | -$4.10 M(-61.6%) | -$37.49 M(+7.6%) |
| June 2012 | - | -$10.69 M(-18.9%) | -$34.84 M(+38.2%) |
| Mar 2012 | - | -$13.17 M(+38.3%) | -$25.21 M(+97.0%) |
| Dec 2011 | -$12.79 M | -$9.52 M(+553.9%) | -$12.79 M(+117.8%) |
| Sept 2011 | - | -$1.46 M(+38.4%) | -$5.87 M(+31.9%) |
| June 2011 | - | -$1.05 M(+38.3%) | -$4.45 M(+28.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$760.70 K(-70.8%) | -$3.47 M(+22.2%) |
| Dec 2010 | -$2.84 M(+81.2%) | -$2.60 M(+6937.3%) | -$2.84 M(+248.9%) |
| Sept 2010 | - | -$37.00 K(-44.5%) | -$813.20 K(-27.9%) |
| June 2010 | - | -$66.70 K(-48.7%) | -$1.13 M(+4.9%) |
| Mar 2010 | - | -$130.00 K(-77.6%) | -$1.07 M(+10.4%) |
| Dec 2009 | -$1.57 M(+296.7%) | -$579.50 K(+65.1%) | -$973.60 K(+141.8%) |
| Sept 2009 | - | -$350.90 K(+2371.1%) | -$402.60 K(+310.0%) |
| June 2009 | - | -$14.20 K(-51.0%) | -$98.20 K(-74.8%) |
| Mar 2009 | - | -$29.00 K(+241.2%) | -$389.50 K(-1.5%) |
| Dec 2008 | -$395.60 K(+322.2%) | -$8500.00(-81.7%) | -$395.60 K(-3.8%) |
| Sept 2008 | - | -$46.50 K(-84.8%) | -$411.20 K(+8.4%) |
| June 2008 | - | -$305.50 K(+770.4%) | -$379.40 K(+369.6%) |
| Mar 2008 | - | -$35.10 K(+45.6%) | -$80.80 K(+57.5%) |
| Dec 2007 | -$93.70 K(+16.0%) | -$24.10 K(+63.9%) | -$51.30 K(-90.8%) |
| Sept 2007 | - | -$14.70 K(+113.0%) | -$554.60 K(+85.6%) |
| June 2007 | - | -$6900.00(+23.2%) | -$298.80 K(+70.2%) |
| Mar 2007 | - | -$5600.00(-98.9%) | -$175.60 K(+113.6%) |
| Dec 2006 | -$80.80 K(-118.5%) | -$527.40 K(-318.7%) | -$82.20 K(-113.7%) |
| Sept 2006 | - | $241.10 K(+107.3%) | $599.50 K(+15.4%) |
| June 2006 | - | $116.30 K(+32.5%) | $519.50 K(+22.1%) |
| Mar 2006 | - | $87.80 K(-43.1%) | $425.60 K(-1.5%) |
| Dec 2005 | $437.70 K(+83.3%) | $154.30 K(-4.2%) | $432.30 K(+2.8%) |
| Sept 2005 | - | $161.10 K(+619.2%) | $420.60 K(+27.0%) |
| June 2005 | - | $22.40 K(-76.3%) | $331.20 K(-3.4%) |
| Mar 2005 | - | $94.50 K(-33.7%) | $342.70 K(+16.9%) |
| Dec 2004 | $238.80 K(+14.5%) | $142.60 K(+98.9%) | $293.10 K(+34.6%) |
| Sept 2004 | - | $71.70 K(+111.5%) | $217.80 K(+17.7%) |
| June 2004 | - | $33.90 K(-24.5%) | $185.00 K(-13.1%) |
| Mar 2004 | - | $44.90 K(-33.3%) | $212.80 K(+6.3%) |
| Dec 2003 | $208.50 K(+58.1%) | $67.30 K(+73.0%) | $200.20 K(+9.4%) |
| Sept 2003 | - | $38.90 K(-37.0%) | $183.00 K(+0.8%) |
| June 2003 | - | $61.70 K(+91.0%) | $181.50 K(+20.7%) |
| Mar 2003 | - | $32.30 K(-35.5%) | $150.40 K(+14.0%) |
| Dec 2002 | $131.90 K(-4.0%) | $50.10 K(+34.0%) | $131.90 K(+51.1%) |
| Sept 2002 | - | $37.40 K(+22.2%) | $87.30 K(+11.2%) |
| June 2002 | - | $30.60 K(+121.7%) | $78.50 K(-18.1%) |
| Mar 2002 | - | $13.80 K(+150.9%) | $95.90 K(-30.2%) |
| Dec 2001 | $137.40 K(-31.4%) | $5500.00(-80.8%) | $137.40 K(-42.3%) |
| Sept 2001 | - | $28.60 K(-40.4%) | $238.00 K(-7.3%) |
| June 2001 | - | $48.00 K(-13.2%) | $256.70 K(+9.6%) |
| Mar 2001 | - | $55.30 K(-47.9%) | $234.20 K(+16.9%) |
| Dec 2000 | $200.30 K(+225.7%) | $106.10 K(+124.3%) | $200.30 K(+78.7%) |
| Sept 2000 | - | $47.30 K(+85.5%) | $112.10 K(+29.7%) |
| June 2000 | - | $25.50 K(+19.2%) | $86.40 K(+7.9%) |
| Mar 2000 | - | $21.40 K(+19.6%) | $80.10 K(+31.1%) |
| Dec 1999 | $61.50 K(+107.1%) | $17.90 K(-17.1%) | $61.10 K(+41.4%) |
| Sept 1999 | - | $21.60 K(+12.5%) | $43.20 K(+100.0%) |
| June 1999 | - | $19.20 K(+700.0%) | $21.60 K(+800.0%) |
| Mar 1999 | - | $2400.00 | $2400.00 |
| Dec 1998 | $29.70 K(+253.6%) | - | - |
| Dec 1997 | $8400.00(-91.2%) | - | - |
| Dec 1996 | $95.20 K(+43.6%) | - | - |
| Dec 1995 | $66.30 K(-0.6%) | - | - |
| Dec 1994 | $66.70 K(+4.7%) | - | - |
| Dec 1993 | $63.70 K | - | - |
FAQ
- What is TherapeuticsMD annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for TherapeuticsMD?
- What is TherapeuticsMD annual EBITDA year-on-year change?
- What is TherapeuticsMD quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for TherapeuticsMD?
- What is TherapeuticsMD quarterly EBITDA year-on-year change?
- What is TherapeuticsMD TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for TherapeuticsMD?
- What is TherapeuticsMD TTM EBITDA year-on-year change?
What is TherapeuticsMD annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TXMD is -$7.60 M
What is the all time high annual EBITDA for TherapeuticsMD?
TherapeuticsMD all-time high annual earnings before interest, taxes, depreciation & amortization is $11.86 M
What is TherapeuticsMD annual EBITDA year-on-year change?
Over the past year, TXMD annual earnings before interest, taxes, depreciation & amortization has changed by -$19.46 M (-164.07%)
What is TherapeuticsMD quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TXMD is -$468.00 K
What is the all time high quarterly EBITDA for TherapeuticsMD?
TherapeuticsMD all-time high quarterly earnings before interest, taxes, depreciation & amortization is $58.36 M
What is TherapeuticsMD quarterly EBITDA year-on-year change?
Over the past year, TXMD quarterly earnings before interest, taxes, depreciation & amortization has changed by +$816.00 K (+63.55%)
What is TherapeuticsMD TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TXMD is -$3.85 M
What is the all time high TTM EBITDA for TherapeuticsMD?
TherapeuticsMD all-time high TTM earnings before interest, taxes, depreciation & amortization is $52.60 M
What is TherapeuticsMD TTM EBITDA year-on-year change?
Over the past year, TXMD TTM earnings before interest, taxes, depreciation & amortization has changed by -$56.45 M (-107.32%)